Jansen et al. examined tumor tissue from 112 patients with ER-positive metastatic BC treated with first-line tamoxifen and showed that six genes associated with the ECM (TIMP3, FN1, LOX, COL1A1, SPARC and TNC) were overexpressed in patients with resistant disease [18]. The gene discussed is TIMP3; the disease is neoplasm.